(Q31802506)

3 July 2017

title

In vitro, ex-vivo and in vivo activities of ethambutol and sparfloxacin alone and in combination against mycobacteria (English)

1 reference

3 July 2017

1 reference

D Kaur

1

1 reference

3 July 2017

G K Khuller

series ordinal

2

1 reference

3 July 2017

publication date

1 January 2001

1 reference

International Journal of Antimicrobial Agents

3 July 2017

published in

1 reference

3 July 2017

volume

17

1 reference

3 July 2017

issue

1

1 reference

3 July 2017

page(s)

51-55

1 reference

Drug-resistant tuberculosis

3 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Mycobacterium avium complex infection and AIDS: advances in theory and practice

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

MICs and MBCs of Win 57273 against Mycobacterium avium and M. tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Synergistic activities of clarithromycin and antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Comparative in vitro activities of ciprofloxacin and other 4-quinolones against Mycobacterium tuberculosis and Mycobacterium intracellulare

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

In vitro susceptibility of Mycobacterium avium complex to the new fluoroquinolone sparfloxacin (CI-978; AT-4140) and comparison with ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Activities of the benzoxazinorifamycin KRM 1648 and ethambutol against Mycobacterium avium complex in vitro and in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Pharmacokinetics of a novel quinolone, AT-4140, in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

In-vitro activities of quinolones against mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Activities of fluoroquinolone, macrolide, and aminoglycoside drugs combined with inhibitors of glycosylation and fatty acid and peptide biosynthesis against Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Accumulation of norfloxacin by Mycobacterium aurum and Mycobacterium smegmatis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

Effectiveness of various antimicrobial agents against Mycobacterium avium complex in the beige mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900308-3

7 January 2021

10.1016/S0924-8579(00)00308-3

Identifiers

DOI

1 reference

3 July 2017

1 reference